AiThority - Artificial Intelligence | News | Insights | AiThority
AEYE Health and Optomed have agreed to enter clinical and commercial collaboration to introduce an AI fundus camera Aurora AEYE. The collaboration includes a clinical trial with the aim to receive U.S. FDA approval for autonomous AI for retinal screening.
Once the clinical trials are commenced and successfully completed, the Aurora AEYE will include Optomed’s handheld fundus camera Aurora and AEYE Health’s AI-based retinal screening system that aims to provide analysis of the retina for diabetic retinopathy changes and receive diagnostic results within 60 seconds.
Recommended AI News: Leaders Versus Laggards In AI: Latest Findings On Generating ROI From Your AI Investments
The Aurora AEYE simplifies the retinal screening process by providing an easy-to-use retinal screening system to examine these patients outside the ophthalmologist’s office, including primary care and endocrinology clinics or pharmacies.
Brands Get Intelligent Creative for AR Across Platforms like TikTok and Instagram with VidMob
VoltaGrid Closes Revolving Credit Facility to Advance its Carbon Reduction Power Generation and Fuels Platform
Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates
Zack Dvey-Aharon, Ph.D., Co-founder and CEO of AEYE Health: “Today, we are taking a big step forward in the direction of providing accurate, affordable and useable solution to detect retinal conditions, prevent blindness and save lives. The use of our advanced AI algorithms and Optomed’s quality handheld fundus cameras sets to democratize diagnostic eye screenings and ensure that all patients who need treatment will receive it on time. We are delighted to team up with Optomed and we look forward to spearheading global efforts to develop AI-based solutions for the early detection of a wide variety of retinal diseases.”
Recommended AI News: IBM Cognos Analytics-Based Business Transformation Going Strong
Laura Piila, Optomed’s Vice President Devices: “We are very excited to begin our cooperation with the AEYE Health team as it enables us to provide another innovative and affordable solution for diabetic retinopathy screening. The solution is perfect for our growth strategy and supports our growth especially in the U.S. as the Aurora AEYE is expected to be the first handheld AI fundus camera available in the U.S. market.”
Optomed disclosed that it has been negotiating of the cooperation already in its H1 financial report on no-name basis due to legal reasons.
Recommended AI News: Daily AI Roundup: The 5 Coolest Things On Earth Today
AIT News Desk is a trained group of web journalists and reporters who collect news from all over the technology landscape. The technical space includes advanced technologies related to AI, ML, ITops, Cloud Security, Privacy and Security, Cyberthreat intelligence, Space, Big data and Analytics, Blockchain and Crypto. To connect, please write to AiT Analyst at news@martechseries.com.
Thoma Bravo Completes Acquisition of Majesco
FSS and Everlink to Drive Card Payments Growth in Canada
Brands Get Intelligent Creative for AR Across Platforms like TikTok and Instagram…
VoltaGrid Closes Revolving Credit Facility to Advance its Carbon Reduction Power…
Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates
K12 SIX Releases Essential Cyber Incident Response Runbook
Comments are closed, but trackbacks and pingbacks are open.
New Release of the expert.ai Platform Accelerates AI-based Natural Language…
Intelligent Voice Assistants and the Future of Contact Center Service
Clarifai Announces New Free AI Collaboration Community
LivePerson Announces Agreement with Starboard Value
AiThority.com covers AI technology news, editorial insights and digital marketing trends from around the globe. Updates on modern marketing tech adoption, AI interviews, tech articles and events.
Copyright © 2022 AiThority. All Rights Reserved. Privacy Policy